Should laparoscopic sleeve gastrectomy specimens be examined histopathologically? Experience of two hundred forty-six patients in university hospital

Öz

INTRODUCTION: Laparoscopic sleeve gastrectomy has become an increasingly common practice in recent years.In this method,about 1000-1100ml stomach is resected.In the case reports or case series,incidental malignant lesions have been reported.The aim of this study was to evaluate the histopathologic results of patients,undergoing laparoscopic sleeve gastrectomy and to discuss the factors affecting the development of malignant lesions.
METHODS: In accordance with the criteria of the World Health Organization,LSG surgeries were performed in246 consecutive patients between January2013and October2017 in a single academic center.Prospectively recorded medical data of these patients were retrospectively reviewed.
RESULTS: 72.4% of the patients were female.The average BMIwas 45,4kg/m2. The most common pathological finding was gastritis.Three patients had incidental malignancy,two patients had atrophic gastritis and extensive intestinal metaplasia.These malign lesions could not be detected in the preoperative evaluations of patients.
DISCUSSION AND CONCLUSION: In recent years there has been a significant increase in the number of bariatric operations performed for elderly patients.In spite of"the older age"was not found as a risk factor for malignancy in our study,the incidence of malignancy in older people is higher than that of younger individuals.Due to increasing of the elderly patient, the malignant lesions may increase.If these lesions have a small size or they locate at subserosa, they may not be detected in preoperative examinations.
Even if no pathologic findings are found in the preoperative endoscopic evaluation,the anterior and posterior wall of the stomach should be fully mobilized to look for possible subserosal lesions in LSG procedure.Histopathologic examination of all gastric specimens should be performed for potential incidental occult malignancies.

Anahtar Kelimeler

• Obesity,Sleeve gastrectomy,GIST,NET

Laparoskopik sleeve gastrektomi spesmenleri histopatolojik olarak incelenmeli mi? Bir üniversite hastanesinin 246 hastadaki deneyimi

Öz

GİRİŞ ve AMAÇ: Morbid obezitenin cerrahi tedavisi için laparaskopik sleeve gastrektomi (LSG) son yıllarda giderek daha sık uygulanan bir yöntem haline gelmiştir. Bu yöntemde yaklaşık 1000-1100ml hacminde bir mide kısmı rezeke edilmektedir. Midenin rezeke edilen bu kısmının değerlendirildiği çalışmaların bir kısmında rastlantısal malign lezyonların görüldüğü bildirilmiştir. Çalışmamızda laparoskopik sleeve gastrektomi ameliyatı yapılan hastaların histopatolojik sonuçlarının değerlendirilmesi, varsa malign lezyonların gelişiminde etki eden faktörlerin tartışılması amaçlanmıştır.
YÖNTEM ve GEREÇLER: Dünya sağlık örgütü ölçütlerine uygun olarak tek akademik merkezde Ocak 2013 – Ekim 2017 tarihleri arasında LSG ameliyatı yapılmış ardışık 246 hastanın prospektif olarak kayıt altına alınan tıbbi verileri retrospektif olarak incelendi.
BULGULAR: Hastaların %72,4’ü kadındı. Ortalama VKİ: 45,41kg/m2 olarak belirlendi. En sık görülen patolojik bulgu gastrit idi. Üç hastada rastlantısal malignite iki hastada atrofik gastrit ve yaygın intestinal metaplazi saptandı. Malignite saptanan hastaların ameliyat öncesi değerlendirmelerinde bu bulgulara rastlanmamıştı.
TARTIŞMA ve SONUÇ: Son yıllarda özellikle ileri yaştaki hastalara uygulanan bariyatrik ameliyat sayılarında ciddi artış vardır. Obezite diğer sistemik hastalıklar için olduğu gibi malignite gelişimi için de risk faktörüdür. Her ne kadar bizim serimizde yaş malignite için anlamlı değişken olarak saptanamamış olsa da yaşlı obez hastaların daha fazla ameliyat ediliyor olması, mide histopatolojilerinde daha fazla malign bulguya rastlanmasına neden olacaktır. Bu malign lezyonların küçük ve subserozal yerleşimli olması halinde, ameliyat öncesi incelemelerde gözden kaçma olasılıkları bulunmaktadır. 
Ameliyat öncesi endoskopik muayene yapılmalı, burada patolojik bulguya rastlanmasa bile LSG prosedüründe midenin ön ve arka yüzü serozal-subserozal lezyonların araştırılması için mutlaka mobilize edilmelidir. Rezeksiyon sonrası tüm mide spesmenlerinin histopatolojik incelemesi, rastlantısal malignitelerin gözden kaçmaması adına uygun olacaktır.

Anahtar Kelimeler

• Obezite,Tüp mide,GİST,LSG,Nöroendokrin tümör

Kaynakça

1. Nguyen NT, Root J, Zainabadi K, Sabio A, Chalifoux S, Stevens CM, et al. Accelerated Growth of Bariatric Surgery With the Introduction of Minimally Invasive Surgery. Arch Surg 2005 140:1198.
2. Lazzati A, Guy-Lachuer R, Delaunay V, Szwarcensztein K, Azoulay D. Bariatric surgery trends in France: 2005-2011. Surg Obes Relat Dis. 2014;10:328–34.
3. Reames BN, Finks JF, Bacal D, Carlin AM, Dimick JB. Changes in Bariatric Surgery Procedure Use in Michigan, 2006-2013. JAMA 2014;312:959–61.
4. Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, et al. Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014. Obes Surg. 2017;27:1–11.
5. Noel P, Nedelcu M, Nocca D, Schneck AS, Gugenheim J, Iannelli A, et al. Revised sleeve gastrectomy: Another option for weight loss failure after sleeve gastrectomy. Surg Endosc Other Interv Tech. 2014;28:1096–102.
6. Derici S, Atila K, Bora S, Yener S. Simple, Safe, and Cost-Effective Technique for Resected Stomach Extraction in Laparoscopic Sleeve Gastrectomy. Gastroenterol Res Pract. 2016;2016:1–4.
7. Yuval JB, Khalaileh A, Abu-Gazala M, Shachar Y, Keidar A, Mintz Y, et al. The True Incidence of Gastric GIST: a Study Based on Morbidly Obese Patients Undergoing Sleeve Gastrectomy. Obes Surg. 2014;24:2134–7.
8. Kinsinger LA, Garber JC, Whipple O. A review of sleeve gastrectomy specimen histopathology. Am Surg. 2016;82:1101–4.

9. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78.
10. Chiappetta S, Theodoridou S, Stier C, Weiner RA. Incidental Finding of GIST During Obesity Surgery. Obes Surg. 2015;25:579–83.
11. Tryggvason G, Gíslason HG, Magnússon MK, Jónasson JG. Gastrointestinal stromal tumors in Iceland, 1990-2003: The Icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005;117:289–93.
12. Gebhart A, Young MT, Nguyen NT. Bariatric surgery in the elderly : 2009 – 2013. Surg Obes Relat Dis. 2017;11:393–8.
13. Avital I, Pisters PWT, Kelsen DP, Willet CG. Cancer of the Stomach. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 9th edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2011. 924-54.
14. Joensuu H, Martin-Broto J, Nishida T, Reichardt P, Schöffski P, Maki RG. Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery. Eur J Cancer. 2015;51:1611–7.
15. Raftopoulos SC, Segarajasingam DS, Burke V, Ee HC, Yusoff IF. A cohort study of missed and new cancers after esophagogastroduodenoscopy. Am J Gastroenterol 2010;105:1292–7.
16. Kulkle, Matthew H Iii ABB, Bergsland E, Berlin JD, Blaszkowsky LS, Emerson L, Engstrom PF, et al. Neuroendocrine Tumors, Version 1.2015 Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2015;13:78–108.
17. Ohanessian SE, Rogers AM, Karamchandani DM. Spectrum of Gastric Histopathologies in Severely Obese American Patients Undergoing Sleeve Gastrectomy. Obes Surg. 2016;26:595–602.
18. Miller GC, Reid AS, Brown IS. The pathological findings seen in laparoscopic sleeve gastrectomies for weight loss. Pathology. 2016;48:228–32.
19. Clapp B. Histopathologic findings in the resected specimen of a sleeve gastrectomy. JSLS. 2015;19:e2013.00259.
20. Rath-Wolfson L, Varona R, Bubis G, Tatarov A, Koren R, Ram E. Gastritis in patients undergoing sleeve gastrectomy. Medicine (Baltimore). 2017;96:e6602.
21. Raess PW, Baird-Howell M, Aggarwal R, Williams NN, Furth EE. Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management. Surg Obes Relat Dis. 2015;11:1020–3.
22. Onzi TR, D’Acampora AJ, De Araújo FM, Baratieri R, Kremer G, Lyra HF, et al. Gastric histopathology in laparoscopic sleeve gastrectomy: Pre- and post-operative comparison. Obes Surg. 2014;24:371–6.
23. Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: A critical reappraisal. World J Gastroenterol. 2012; 18: 1279–85.